In its first quarter of 2026, Chemed Corporation delivered revenue growth driven by both its VITAS hospice care and Roto-Rooter plumbing services segments, maintaining leadership in highly regulated and fragmented industries. However, margin compression due to higher operating costs in hospice care and competitive pricing pressures in plumbing tempered earnings gains. The company’s decentralized structure supports focused management but leaves growth reliant on regulatory navigation, skilled labor retention, and efficient service delivery. Ongoing Medicare reimbursement risk and intense competition present persistent constraints. Monitoring VITAS’s compliance with Medicare rules and Roto-Rooter's ability to innovate customer service remain critical for Chemed’s trajectory.